Thryvv : ratio page

Pfizer

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Nov2008
Nov2007
Nov2006
Nov2005
Nov2004
Valuation Parameters:
PE(x)
4.66
5.68
21.73
37.96
37.58
PCE(x)
4.49
5.53
19.35
31.74
30.55
Price/Book(x)
1.55
2.99
5.42
7.91
6.02
Yield(%)
2.67
4.25
1.61
1.11
1.72
EV/Net Sales(x)
1.16
1.97
2.72
3.67
2.36
EV/Core EBITDA(x)
3.83
3.04
10.06
16.58
14.56
EV/EBIT(x)
2.03
3.22
12.31
22.09
20.27
EV/CE(x)
0.47
1.00
1.79
2.50
2.96
MCap / Sales
1.89
2.62
3.14
3.98
2.59
Growth Ratio:
Net Sales Growth(%)
0.03
0.03
9.11
4.32
14.45
Core EBITDA Growth(%)
-53.51
140.16
33.45
42.40
49.16
EBIT Growth(%)
-7.14
177.39
45.26
48.73
76.40
PAT Growth(%)
-11.89
219.75
50.33
58.64
88.22
EPS Growth(%)
-11.89
219.75
50.33
53.09
88.22
Financial Stability Ratios:
Total Debt/Equity(x)
0.00
0.00
0.00
0.00
0.04
Current Ratio(x)
1.86
1.69
1.49
1.40
2.23
Quick Ratio(x)
1.72
1.57
1.35
1.26
1.79
Total Debt/Mcap(x)
0.00
0.00
0.00
0.00
0.01
Operational & Financial Ratios:
Earnings Per Share (Rs)
100.39
113.94
35.63
23.70
15.48
CEPS(Rs)
104.12
117.15
40.01
28.34
19.05
DPS(Rs)
12.50
27.50
12.50
10.00
10.00
Book NAV/Share(Rs)
301.96
216.74
142.90
113.68
96.68
Tax Rate(%)
28.52
24.67
34.62
36.77
40.16
Margin Ratios:
Core EBITDA Margin(%)
19.12
19.60
20.80
15.91
13.04
EBIT Margin(%)
52.99
56.52
20.42
15.37
10.83
Pre Tax Margin(%)
52.99
56.52
20.41
15.34
10.71
PAT Margin (%)
37.88
42.58
13.35
9.70
6.41
Cash Profit Margin (%)
39.28
43.78
14.99
11.60
7.88
Performance Ratios:
ROA(%)
18.37
26.37
10.07
9.39
9.35
ROE(%)
38.71
63.36
27.78
22.90
16.81
ROCE(%)
54.15
84.11
42.50
35.52
27.71
Asset Turnover(x)
0.48
0.62
0.75
0.97
1.46
Sales/Fixed Asset(x)
5.62
5.16
4.71
4.43
4.71
Working Capital/Sales(x)
1.00
1.42
2.34
2.89
3.32
Efficiency Ratios:
Fixed Capital/Sales(x)
0.18
0.19
0.21
0.23
0.21
Receivable days
28.15
30.12
35.19
39.05
34.52
Inventory Days
50.96
44.60
43.53
41.49
43.07
Payable days
186.85
219.95
251.41
211.29
168.30